RT Journal Article
SR Electronic
T1 SARS-CoV-2 genomic monitoring in the São Paulo State unveils new sublineages of the AY.43 strain
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.29.21266819
DO 10.1101/2021.11.29.21266819
A1 Lima, Alex Ranieri Jerônimo
A1 Ribeiro, Gabriela
A1 Viala, Vincent Louis
A1 de Lima, Loyze Paola Oliveira
A1 Martins, Antonio Jorge
A1 Santos Barros, Claudia Renata dos
A1 Marqueze, Elaine Cristina
A1 de Souza Todao Bernardino, Jardelina
A1 Moretti, Debora Botequio
A1 Rodrigues, Evandra Strazza
A1 Santos, Elaine Vieira
A1 Brassaloti, Ricardo Augusto
A1 de Lello Rocha Campos Cassano, Raquel
A1 Mariani, Pilar Drummond Sampaio Corrêa
A1 Clemente, Luan Gaspar
A1 Assato, Patricia Akemi
A1 Silva da Costa, Felipe Allan da
A1 Poleti, Mirele Daiana
A1 Lesbon, Jessika Cristina Chagas
A1 Mattos, Elisangela Chicaroni
A1 Banho, Cecilia Artico
A1 Sacchetto, Lívia
A1 Moraes, Marília Mazzi
A1 Palmieri, Melissa
A1 da Silva, Fabiana Erica Vilanova
A1 Grotto, Rejane Maria Tommasini
A1 Souza-Neto, Jayme A.
A1 Giovanetti, Marta
A1 de Alcantara, Luiz Carlos Junior
A1 Nogueira, Maurício Lacerda
A1 Fukumasu, Heidge
A1 Coutinho, Luiz Lehmann
A1 Kashima, Simone
A1 Neto, Raul Machado
A1 Covas, Dimas Tadeu
A1 Slavov, Svetoslav Nanev
A1 Elias, Maria Carolina
A1 Sampaio, Sandra Coccuzzo
YR 2021
UL http://medrxiv.org/content/early/2021/11/30/2021.11.29.21266819.abstract
AB Delta VOC is highly diverse and more than 120 sublineages have been identified in Pango lineages with the continuous description of emerging ones. Brazil is now one of the most vaccinated countries against SARS-CoV-2 in the world which can enhance the emergence of viral mutations related to improved viral fitness. In this study, we identified two novel sublineages of the AY.43 lineage which were classified as AY.43.1 and AY.43.2 as observed on the specific clustering on the obtained phylogenetic tree. The novel sublineages were defined by the following characteristic nonsynonymous mutations ORF1ab:A4133V and ORF3a:T14I for AY.43.1 and ORF1ab:G1155C for AY.43.2. The majority of the analyzed sequences of both lineages were Brazilian, which shows that probably these two emerging sublineages have Brazilian origin. It is still unknown how these two sublineages are disseminated in São Paulo State and Brazil and their potential impact on the ongoing vaccination process. However, the performed study reinforces the importance of the SARS-CoV-2 genome monitoring for timely identification of emerging SARS-CoV-2 variants which can impact the ongoing SARS-CoV-2 vaccination and public health policies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Butantan Foundation, Fundação de Amparo à Pesquisa do Estado de São Paulo (Grant Numbers: 2020/10127; 2020/06441-2), Fundação Hemocentro Ribeirão PretoAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Ethics Committee of the Faculty of Medicine of Ribeirao Preto, University of Sao Paulo (CAAE: 50367721.7.1001.5440).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesGenomes used in this study can be obtained from GISAID, using accession ID present in Supplementary Files 1 and 2. https://repositorio.butantan.gov.br/handle/butantan/3990?locale=en